Reuters logo
EU regulator likely to fine J&J, Novartis next month - sources
November 22, 2013 / 1:25 PM / 4 years ago

EU regulator likely to fine J&J, Novartis next month - sources

BRUSSELS, Nov 22 (Reuters) - EU antitrust regulators are set to fine drugmakers Johnson & Johnson and Novartis next month for blocking the sale of a cheaper generic painkiller in the Netherlands, two people familiar with the matter said on Friday.

“The European Commission is likely to issue a decision next month,” one of the people said.

In its charge sheet sent to the companies in January, the European Union competition watchdog said the so-called “pay-for-delay” deal against the generic versions of fentanyl hurt Dutch consumers and healthcare providers.

Commission spokesman for competition policy, Antoine Colombani, declined to comment. Johnson & Johnson and Novartis were not immediately available for comment.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below